Cargando…

Tumor BRCA testing in ovarian cancer and EQA scheme: our experience of a critical evaluation

Next generation sequencing (NGS) is a widespread molecular biology method integrated into clinical practice to detect genetic variants, for diagnostic and prognostic purposes. The scheduled external quality assessments (EQA) is integral part of clinical molecular laboratory quality assurance. The EQ...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Paolis, Elisa, Concolino, Paola, Onori, Maria Elisabetta, Santonocito, Concetta, Marchetti, Claudia, Fagotti, Anna, Scambia, Giovanni, Urbani, Andrea, Minucci, Angelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2021
Materias:	Mini Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604882/ https://www.ncbi.nlm.nih.gov/pubmed/34643925 http://dx.doi.org/10.1007/s11033-021-06812-0

Ejemplares similares

BRCA testing delay during the COVID-19 pandemic: How to act?
por: Minucci, Angelo, et al.
Publicado: (2020)

A commentary on the discrepancy between blood and tumour BRCA testing: An open question
por: De Paolis, Elisa, et al.
Publicado: (2022)

BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic
por: Minucci, Angelo, et al.
Publicado: (2020)

A Novel GCK Large Genomic Rearrangement in a Patient with MODY-2 Detected by Clinical Exome Sequencing
por: Concolino, Paola, et al.
Publicado: (2022)

Next-Generation Sequencing for Screening Analysis of Cystic Fibrosis: Spectrum and Novel Variants in a South–Central Italian Cohort
por: De Paolis, Elisa, et al.
Publicado: (2023)

Identification and Molecular Characterization of a Novel Large-Scale Variant (Exons 4_18 Loss) in the LDLR Gene as a Cause of Familial Hypercholesterolaemia in an Italian Family
por: Concolino, Paola, et al.
Publicado: (2023)

A Whole Germline BRCA2 Gene Deletion: How to Learn from CNV In Silico Analysis
por: Scaglione, Giovanni Luca, et al.
Publicado: (2018)

High-resolution melting analysis coupled with next-generation sequencing as a simple tool for the identification of a novel somatic BRCA2 variant: a case report
por: Costella, Alessandra, et al.
Publicado: (2018)

Preliminary molecular evidence associating a novel BRCA1 synonymous variant with hereditary ovarian cancer syndrome
por: Minucci, Angelo, et al.
Publicado: (2018)

Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine
por: De Paolis, Elisa, et al.
Publicado: (2023)

NLR and BRCA mutational status in patients with high grade serous advanced ovarian cancer
por: Marchetti, Claudia, et al.
Publicado: (2021)

A Novel ATM Pathogenic Variant in an Italian Woman with Gallbladder Cancer
por: De Paolis, Elisa, et al.
Publicado: (2021)

Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients
por: Buttarelli, Marianna, et al.
Publicado: (2022)

Commentary: Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances
por: Minucci, Angelo, et al.
Publicado: (2021)

Interpretation of EQA results and EQA-based trouble shooting
por: Kristensen, Gunn Berit Berge, et al.
Publicado: (2017)

Duplex high resolution melting analysis (dHRMA) to detect two hot spot CYP24A1 pathogenic variants (PVs) associated to idiopathic infantile hypercalcemia (IIH)
por: De Bonis, Maria, et al.
Publicado: (2021)

Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer
por: Nero, Camilla, et al.
Publicado: (2022)

Glucose-6-phosphate dehydrogenase deficiency and hydroxychloroquine in the COVID-19 era: a mini review
por: Onori, Maria Elisabetta, et al.
Publicado: (2021)

Spectrum of Germline BRCA1 and BRCA2 Variants Identified in 2351 Ovarian and Breast Cancer Patients Referring to a Reference Cancer Hospital of Rome
por: Santonocito, Concetta, et al.
Publicado: (2020)

Genetics and Sport Injuries: New Perspectives for Athletic Excellence in an Italian Court of Rugby Union Players
por: Onori, Maria Elisabetta, et al.
Publicado: (2022)

BRCA1 and BRCA2 Testing through Next Generation Sequencing in a Small Cohort of Italian Breast/Ovarian Cancer Patients: Novel Pathogenic and Unknown Clinical Significance Variants
por: Concolino, Paola, et al.
Publicado: (2019)

Estimating the parasitaemia of Plasmodium falciparum: experience from a national EQA scheme
por: Manser, Monika, et al.
Publicado: (2013)

Spectrum of DICER1 Germline Pathogenic Variants in Ovarian Sertoli–Leydig Cell Tumor
por: De Paolis, Elisa, et al.
Publicado: (2021)

Demystifying EQA statistics and reports
por: Coucke, Wim, et al.
Publicado: (2017)

BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making
por: Pavese, Francesco, et al.
Publicado: (2022)

EQA/PT scheme to improve the equivalence of enzymatic results between mutual recognition laboratories in Beijing
por: Tong, Qing, et al.
Publicado: (2021)

What’s beyond BRCA Mutational Status in High Grade Serous Ovarian Cancer? The Impact of Hormone Receptor Expression in a Large BRCA-Profiled Ovarian Cancer Patient Series: A Retrospective Cohort Study
por: Perrone, Emanuele, et al.
Publicado: (2022)

External Quality Assessment (EQA) for Molecular Diagnostics of Zika Virus: Experiences from an International EQA Programme, 2016–2018
por: Donoso Mantke, Oliver, et al.
Publicado: (2018)

External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot scheme
por: Esposito Abate, Riziero, et al.
Publicado: (2022)

Inter-Laboratory Comparisons and EQA in the Mediterranean Area
por: Haliassos, Alexander
Publicado: (2018)

The challenge of producing an EQA for the COVID-19 pandemic
por: Badrick, Tony, et al.
Publicado: (2020)

Evaluation of a worldwide EQA scheme for complex clonality analysis of clinical lymphoproliferative cases demonstrates a learning effect
por: Keppens, Cleo, et al.
Publicado: (2021)

Correction to: External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot scheme
por: Esposito Abate, Riziero, et al.
Publicado: (2022)

The Relationship between ACE, ACTN3 and MCT1 Genetic Polymorphisms and Athletic Performance in Elite Rugby Union Players: A Preliminary Study
por: Pasqualetti, Massimo, et al.
Publicado: (2022)

A Computational Framework for Comprehensive Genomic Profiling in Solid Cancers: The Analytical Performance of a High-Throughput Assay for Small and Copy Number Variants
por: Giacò, Luciano, et al.
Publicado: (2022)

Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing
por: Jurmeister, Philipp, et al.
Publicado: (2021)

Genes and Pseudogenes: Complexity of the RCCX Locus and Disease
por: Carrozza, Cinzia, et al.
Publicado: (2021)

Structure-Function of the Tumor Suppressor BRCA1
por: Clark, Serena L., et al.
Publicado: (2012)

The prognostic role of systemic inflammatory markers in apparent early-stage ovarian cancer
por: Bizzarri, Nicolò, et al.
Publicado: (2022)

The role of EQA in harmonization in laboratory medicine – a global effort
por: Jones, Graham R.D.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ar711u579uuqm6r05ts59jh3d3